Brokerage firms Nuvama, CLSA, and Macquarie have highlighted strong growth prospects for TCS, Bajaj Finance, and IRCTC, ...

The retail sector delivered a mixed performance during the festive season, with select pockets emerging as bright spots, ...

TCS shares surge 6% post Q3 results, brokerages optimistic, net profit up 5.5%, dividend declared, target prices revised.

Dr Reddy’s share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to ’Buy’ with a target of ...

The surge in Dr. Reddy's share followed an upgrade by domestic brokerage Nuvama, which raised its rating on the stock to 'Buy ...

Of this, the startup has already pocketed $10 Mn from Nuvama Private Wealth and a US-based VC firm will infuse another $10 Mn ...

Avenue Supermarts, operator of DMart, is expected to report an 18% YoY revenue growth to Rs 16,016 crore for Q3FY25, with net ...

Metal stocks which have fallen around 4.5% so far in January are expected to remain in focus on account of their Q3FY25 ...

Nomura, on January 6, upgraded SBI Card share to ‘Buy’ from ‘Reduce’ on rising share of top metro cities in its new card ...

DRL also faces headwinds because of increasing competitive intensity in the generic market and exchange rate volatility.

Expects catering services revenues to grow at 15% CAGR over next three years. Key growth levers: Higher share of reserved ...

Multi-Manager ICVC also sold 4.35 lakh shares or 0.52 percent stake in Dr Lal PathLabs at Rs 2,997.11 per share.